 
|
Pancreatic Cancer News and Archives
For access to the
Select Abstractssm section, please click here
For educational purposes
only; not to be relied upon. Please read Pancreatica Disclaimer
- 2006
First Quarter
-
- A Phase I Study of Oral Uracil-Tegafur
Prior to Weekly Intravenous Gemcitabine in Patients with Advanced
Pancreatic Cancer
March 27, 2006
- ...more
-
- Raltitrexed-Eloxatin Salvage
Chemotherapy in Gemcitabine-Resistant Metastatic Pancreatic Cancer
March 27, 2006
- ...more
-
- Folate Intake and Pancreatic
Cancer Incidence: A Prospective Study of Swedish Women and Men
March 15, 2006
- ...more
-
- Gemcitabine Combined with
5-Fluorouracil for the Treatment of Advanced Carcinoma of the
Pancreas
March 1, 2006
- ...more
-
- Liposomal Oxaliplatin in
the Treatment of Advanced Cancer: A Phase I Study
March 1, 2006
- ...more
-
- Multi-Detector Row CT of
Pancreatic Islet Cell Tumors
March 1, 2006
- ...more
-
- Oxaliplatin Combined with
5-FU in Second Line Treatment of Advanced Pancreatic Adenocarcinoma.
Results of a Phase II Trial
March 1, 2006
- ...more
-
- Phase I Trial Evaluating
the Safety of Bevacizumab with Concurrent Radiotherapy and Capecitabine
in Locally Advanced Pancreatic Cancer
March 1, 2006
- ...more
-
- Phase I-II Trial of Weekly
Gemcitabine Plus High-Dose 5-Fluorouracil and Leucovorin in Advanced
Pancreatic Cancer
March 1, 2006
- ...more
-
- The Long-Term Survival of
a Patient with Pancreatic Cancer with Metastases to the Liver
after Treatment with the Intravenous {Alpha}-Lipoic Acid/Low-Dose
Naltrexone Protocol
March 1, 2006
- ...more
-
- Immunomodulatory Impact of
Interferon-Alpha in Combination with Chemoradiation of Pancreatic
Adenocarcinoma (Capri)
February 17, 2006
- ...more
-
- A Phase I Study of Eniluracil/5-FU
in combination with Radiation Therapy for Potentially Resectable
and/or Unresectable Cancer of the Pancreas and Distal Biliary
Tract
- February 1, 2006
- ...more
-
- Clinical Features of Long
Time Survivors with Unresectable Pancreatic Cancer Treated by
Gemcitabine Alone
- February 1, 2006
- ...more
-
- Gemcitabine and Oxaliplatin
(GEMOX) in Gemcitabine Refractory Advanced Pancreatic Adenocarcinoma:
A Phase II Study
- January 24, 2006
- ...more
-
- Method of Pyloric Reconstruction
and Impact Upon Delayed Gastric Emptying and Hospital Stay after
Pylorus-Preserving Pancreaticoduodenectomy
- February 1, 2006
- ...more
-
- Subsequent Resection of Locally
Advanced Pancreatic Carcinoma after Chemoradiotherapy
- February 1, 2006
- ...more
-
- Surgery for Gastrinoma and
Insulinoma in Multiple Endocrine Neoplasia Type 1
- February 1, 2006
- ...more
-
- Evaluation of the Efficacy
of Combined Continuous Arterial Infusion and Systemic Chemotherapy
for the Treatment of Advanced Pancreatic Carcinoma
- January 20, 2006
- ...more
-
- Phase II Study of Fixed Dose
Rate Gemcitabine with Cisplatin for Metastatic Adenocarcinoma
of the Pancreas
- January 20, 2006
- ...more
-
- Phase II Study of Temozolomide
and Thalidomide in Patients with Metastatic Neuroendocrine Tumors
- January 20, 2006
- ...more
-
- A Multi-Institutional Phase
II Trial of Preoperative Full-Dose Gemcitabine and Concurrent
Radiation for Patients with Potentially Resectable Pancreatic
Carcinoma
- January 15, 2006
- ...more
-
- DNA Methylation Alterations
in the Pancreatic Juice of Patients with Suspected Pancreatic
Disease
- January 15, 2006
- ...more
-
- Serum Markers in Patients
with Resectable Pancreatic Adenocarcinoma: Macrophage Inhibitory
Cytokine 1 Versus CA19-9
- January 15, 2006
- ...more
-
- Multicenter Phase-I/II Study
Using a Combination of Gemcitabine and Docetaxel in Metastasized
and Unresectable, Locally Advanced Pancreatic Carcinoma
- January 12, 2006
- ...more
-
- Combined Chemoradiotherapy
for Isolated Local Recurrence after Primary Resection of Pancreatic
Cancer
- January 11, 2006
- ...more
-
- Fixed Dose-Rate Infusion
of Gemcitabine in Combination with Cisplatin and UFT in Advanced
Carcinoma of the Pancreas
- January 11, 2006
- ...more
-
- A Phase II Study of Weekly
Cisplatin and Gemcitabine in Patients with Advanced Pancreatic
Cancer: Is this a Strategy Still Worth Pursuing?
- January 1, 2006
- ...more
-
- Comparison of Standard-Dose
and Low-Dose Gemcitabine Regimens in Pancreatic Adenocarcinoma
Patients: A Prospective Randomized Trial
- January 1, 2006
- ...more
-
- Decreased Total Lymphocyte
Counts in Pancreatic Cancer: An Index of Adverse Outcome
January 1, 2006
- ...more
-
- Differences in Survival for
Patients with Resectable Versus Unresectable Metastases From
Pancreatic Islet Cell Cancer
- January 1, 2006
- ...more
-
- Effect of Neoadjuvant Chemoradiation
on Operative Mortality and Morbidity for Pancreaticoduodenectomy
- January 1, 2006
- ...more
-
- Efficacy and Tolerability
of Pegylated IFN-alpha in Patients with Neuroendocrine Gastroenteropancreatic
Carcinomas
- January 1, 2006
- ...more
-
- Gemcitabine and Oxaliplatin
in Patients with Pancreatic Adenocarcinoma: Clinical and Pharmacokinetic
Data
January 1, 2006
- ...more
-
- Initial Experience with Hand-Assisted
Laparoscopic Distal Pancreatectomy
January 1, 2006
- ...more
-
- Meta-Analysis of Inoperable
Pancreatic Cancer: Gemcitabine Combined with Cisplatin Versus
Gemcitabine Alone
- January 1, 2006
- ...more
-
- Neuroendocrine Tumors of
the Pancreas
- January 1, 2006
- ...more
-
- Phase I Trial of Sorafenib
and Gemcitabine in Advanced Solid Tumors with an Expanded Cohort
in Advanced Pancreatic Cancer
- January 1, 2006
- ...more
-
- Second-Line Intra-Arterial
Chemotherapy in Advanced Pancreatic Adenocarcinoma
January 1, 2006
...more
-
- Selective Hepatic Artery
Embolization for Treatment of Patients with Metastatic Carcinoid
and Pancreatic Endocrine Tumors
- January 1, 2006
- ...more
-
- Somatostatin Analogues in
Treatment of Gastrointestinal and Pancreatic Neuroendocrine Tumors
- January 1, 2006
- ...more
-
- Targeted Radionuclide Therapy
with 90Y-DOTATOC in Patients with Neuroendocrine Tumors
- January 1, 2006
- ...more
-
- The Role of Cytoreductive
Hepatic Surgery as an Adjunct to the Management of Metastatic
Neuroendocrine Carcinomas
- January 1, 2006
- ...more
|
